Press release
Cancer Research UK-funded scientists in Dundee have discovered how some cancer drugs can target the disease while sparing healthy tissue.
Press release
Cancer Research UK-funded scientists in Dundee have discovered how some cancer drugs can target the disease while sparing healthy tissue.
Press release
Scotland’s First Minister has visited a multi-million pound centre that will build on Dundee’s standing as a world leader in health and life sciences research.
Press release
The University of Dundee has been named the UK’s best for supporting spinout businesses, according to industry-leading analysis.
Press release
University of Dundee spinout Amphista Therapeutics today announced the delivery of the first discovery milestone under a collaboration and licence agreement with global biopharmaceutical company Bristol Myers Squibb.
Press release
University of Dundee spinout company Tay Therapeutics has announced a licensing deal potentially worth over $50 million in upfront and milestone payments, plus royalties.
Press release
World-leading and collaborative research undertaken at the University of Dundee has been honoured at one of the Life Sciences sector’s most prestigious award ceremonies.
Press release
A new University of Dundee spinout opportunity hopes to create vaccines against Strep A as well as novel vaccines for other human and animal diseases, while reducing our reliance on antibiotics.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
Press release
The University of Dundee has welcomed the signing of the Tay Cities Deal, which will boost efforts to capitalise on our world-class strengths in biomedicine and forensic science, creating hundreds of new jobs and attracting further investment.
Press release
A University of Dundee spinout company developing treatments for eczema, rheumatoid arthritis and other inflammatory conditions has completed its first round of private investment.
Press release
The University of Dundee has been named the best seat of learning in Scotland for supporting spinout businesses, according to new rankings
Press release
Three spinout projects from the University of Dundee with the potential to deliver significant healthcare benefits have received more than £250,000 from Scottish Enterprise to support their development.
Press release
The University of Dundee is to partner with global biopharmaceutical company Almirall to develop new treatments for severe skin diseases with high level of unmet medical need.
Press release
Researchers at the University of Dundee are looking to transform pharmaceutical and cosmetics testing with their spinout venture that offers an alternative for many experiments currently only performed in animals.
Press release
University of Dundee researchers hope to turn their spinout venture into a biotech company worth hundreds of millions of pounds by helping to treat people with eczema, rheumatoid arthritis and other inflammatory conditions.
Press release
The Universities of Dundee and Edinburgh are playing key roles in a €77.7 million pan-European consortium seeking to accelerate the development of therapies for Covid-19 and future coronaviruses.
Press release
The University of Dundee is working with partners around the world to rapidly repurpose existing drugs against Covid-19.
Press release
University spinout, Amphista Therapeutics, has announced a multi-million pound funding package.